The global Liraglutide Injection market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Liraglutide Injection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liraglutide Injection market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Novo Nordisk … Segment by Regions North America Europe China Japan Segment by Type Type I Type II Segment by Application Hypoglycemic Weight Lose Others